Inventor profile of:

Gary Lynch

City:

Irvine, California

Country:

United States

Published Applications:

11

Last publication date:

2013-05-16

Top Assignees for applications by Gary Lynch

The entities that hold a legal rights for patent applications filed by inventor Lynch Gary:

Recent patent applications by Lynch Gary

Gary Lynch from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-05-16
US20130123248A1
Human necessities

PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION

#2 | 2011-12-15
US20110306601A1
Human necessities

PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION

#3 | 2010-03-18
US20100069377A1
Human necessities

TREATMENT OF FEMALE SEXUAL DYSFUNCTION BY COMPOUNDS THAT POSITIVELY MODULATE AMPA-TYPE GLUTAMATE RECEPTORS

#4 | 2009-07-30
US20090192199A1
Human necessities

PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION

#5 | 2008-07-24
US20080176793A1
Human necessities

UPREGULATING ACTIVITY OR EXPRESSION OF BDNF TO MITIGATE COGNITIVE IMPAIRMENT IN ASYMPTOMATIC HUNTINGTON'S SUBJECTS

#6 | 2008-06-12
US20080139472A1
Human necessities

UPREGULATING BDNF LEVELS TO MITIGATE MENTAL RETARDATION

#7 | 2008-02-14
US20080038200A1
Chemistry; metallurgy

MODEL FOR NEURODEGENERATIVE DISEASES INVOLVING AMYLOID ACCUMULATION

#8 | 2007-04-26
US20070092865A1
Physics

Detection and characterization of psychoactives using parallel multi-site assays in brain tissue

#9 | 2007-03-06
US9961381
-

Determining the effect of a substance on sequestration, uptake, and accumulation of amyloid in brain cells

#10 | 2006-10-10
US10774262
-

Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

#11 | 2005-10-13
US20050228019A1
Human necessities

Enhancement of ampakine-Induced facilitation of synaptic responses by cholinesterase inhibitors

InventorID:

249187 ⎘